ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646159 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646159; 2) Community: the network communities that were significantly associated with the response to NSC 646159; 3) Molecule: the relationships between components within communities and NSC 646159; 4) MDR: the compounds that were significantly associated with the NSC 646159.

NSC Compound Enrichment Correlation
NSC 100046 Elephantopin 0.0209467683758282 0.47295739
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0209467683758282 0.61774682
NSC 316158 Null 0.0209467683758282 0.27172402
NSC 330500 Macbecin II 0.0209467683758282 0.57068311
NSC 351078 Hydrazinecarbothioamide, N,N-dimethyl-2-[1-(2-pyridinyl)- ethylidene]-, N-oxide 0.0209467683758282 0.61209468
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0209467683758282 0.54745246
NSC 606498 Camptothecin Derivative 0.0209467683758282 0.24431999
NSC 609699 Topotecan hydrochloride 0.0209467683758282 0.22376899
NSC 638646 4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride 0.0209467683758282 0.58507386
NSC 644960 Null 0.0209467683758282 0.17551535
Total:86  Current:41    [First] [Prev] [Next] [Last]